Search All Sites
RSS Feed
Print this page
PDF
This Article studied the actual effect of the United States Supreme Court’s decision in Ashcroft...
This article discusses the path of shifting from a career in the active practice of...
OpenURL
This article explores the prudence and legal validity of approaching pharmaceutical development at a level...
Co-authored with Royce W. Smith, Esq. of Philadelphia.
This article critiques the judicial penchant for combining drug and device tort cases together for...
Now in its 16th Edition, the Federal Civil Rules Handbook dissects each of the Federal...
Gathering principal text from the practitioner's/judicial publication (Federal Civil Rules Handbook), the Student's Guide assembles...
A set of full-color graphical illustrations of the operation of the leading principles, rules, and...
With this Volume 12B, the principal text of the Federal Civil Rules Handbook is incorporated...
This chapter discusses the U.S. Court of Appeals' decision in Siracusano v. Matrixx Initiatives, Inc.,...
This chapter discusses the U.S. Supreme Court's 2009 opinion in Ashcroft v. Iqbal, with early...
This chapter introduces the concept of "off-label medicine" (namely, off-label use, prescription, and promotion), by...
In FDLI's principal work on off-label medicine, this Chapter summarizes the evolution of off-label practices...
This chapter introduces the intricate regulatory scheme of postmarketing regulations that restrict the commercialization of...
This chapter surveys and analyzes the legal dimensions of advertising prescription medical products directly to...
A strategic overview of the process of jury selection. Co-authored with Walter R. Milbourne, Esq....